{
  "ptid_time": "094_S_1417_2009-02-19",
  "img_path": "/data/qiuhui/data/adni/images/094_S_1417/2009-02-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 39,060 mm³, 30.1% above the reference mean. With a Z-score of 0.71 (76.3th percentile), this represents normal volume ; hippocampal volume measures 5,291 mm³, 34.1% below the reference mean. With a Z-score of -3.41 (0.0th percentile), this represents profound atrophy; whole brain volume measures 1,086,140 mm³, 4.3% below the reference mean. With a Z-score of -0.60 (27.3th percentile), this represents normal volume ; entorhinal cortex volume measures 2,214 mm³, 48.1% below the reference mean. With a Z-score of -3.33 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 16,020 mm³, 19.5% below the reference mean. With a Z-score of -1.62 (5.2th percentile), this represents moderate atrophy; middle temporal gyrus volume measures 19,850 mm³, 11.4% below the reference mean. With a Z-score of -0.94 (17.3th percentile), this represents normal volume . ",
  "text_data": "Age is 64.6 years. Gender is Male. Education: 12 years. MMSE: 26.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound atrophy in the hippocampus and entorhinal cortex, both critical regions for memory and early Alzheimer's pathology, alongside moderate atrophy in the fusiform gyrus. The MMSE score of 26 is borderline, but the structural changes suggest neurodegeneration. The absence of APOE4 does not rule out Alzheimer's, as atrophy patterns are highly suggestive.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal Alzheimer's given hippocampal/entorhinal atrophy)  \n**Confidence:** **Medium** (clinical correlation needed to exclude other causes of atrophy, but imaging strongly supports MCI due to Alzheimer's-like pathology)  \n\n*Note: Progression to dementia is likely if hippocampal/entorhinal atrophy worsens. Follow-up with CSF biomarkers (e.g., Aβ42, p-tau) or amyloid PET would increase diagnostic certainty.*",
  "timestamp": "2025-07-26T10:24:38.634716"
}